Statement by Mr. Nicolas Sarkozy, President of the Republic, on the fight against Alzheimer's disease, in Paris on September 3, 2007.

France Nicolas Sarkozy · President of France

3 September 2007 · Installation of the commission chaired by Professor Joël Ménard on the fight against Alzheimer's disease · Paris, France

Context
Sarkozy addressed a commission chaired by Professor Joël Ménard in Paris on September 3, 2007, launching France's new national Alzheimer Plan.
Main themes
Alzheimer's disease, national action plan, medical research and diagnosis, patient care and dignity, family caregiver support, epidemiological monitoring, French scientific excellence, chronic disease management, societal mobilization, healthcare funding
Duration
~11 min
40th percentile
Words
1,358
40th percentile
Sentences
86
56th percentile
Readability
50
62nd percentile
Grade
10.2
23rd percentile
Syntax
2.70
13th percentile
Vocabulary
2.23
57th percentile

Translated from French

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 84%83%
  • Ceremonial 7%7%
  • Institutional 6%6%
  • Technological 4%3%
  • Geopolitical 0%0%
  • Economic 0%0%
  • Environmental 0%0%
  • Not in focus 1%

86 sentences in 22 paragraphs

Mr. Prime Minister,

Ladies and Gentlemen Ministers,

Mr. President of the Alzheimer Plan Commission,

Ladies and Gentlemen members of the commission,

I am pleased to mark my personal commitment to the fight against Alzheimer’s disease and related illnesses by bringing you together for the installation of the commission chaired by Professor Joël MENARD. In truth, I consider it my responsibility to take a decisive step forward in our collective action against these diseases and their consequences.

Why? Alzheimer’s disease affects more than 850,000 people in France. It accounts for 225,000 new cases each year. A 10-year increase in our life expectancy quadruples the likelihood of developing the disease. There is the coldness of arithmetic. There are also human realities. It is a disease that strikes nearly all families. But Alzheimer’s disease is more than just an illness. Born of longevity, it is an inexorable affliction that turns the men and women affected into nothing less than "living tombs." Alzheimer’s disease also weighs heavily on loved ones, bringing them a daily share of suffering. In the face of this disease, about which we still know so little, we must react. It is a mobilization of society as a whole that I wish to inspire.

We must be clear-eyed about the challenge that the fight against Alzheimer’s disease and related illnesses represents for our society. The patients and their families, who are increasingly numerous, will need effective support that respects the dignity of individuals. I want each person affected to be welcomed, cared for, and treated properly. I want the loved ones who care for them to receive better assistance. I want to restore hope to those who think they can do nothing. We would not be true to ourselves and our values if it were otherwise. It is the honor of a civilization to help those whom the disease slowly destroys.

I want an Alzheimer Plan that meets this national challenge. That is why the Alzheimer Plan will be supported by new resources provided by the medical franchise.

Certainly, much has already been written and done about Alzheimer’s disease. The two plans of 2001 and 2004 established a status for the disease, which now falls into the category of long-term conditions. They created memory consultations and memory resource and research centers for diagnosis. Alzheimer units are developing in care facilities. Associations have opened day care centers and respite services to give families time to breathe. Knowledge of the disease and treatments, still insufficient, has progressed. The foundations of the fight against the disease have been laid. The immense task remains to better meet the expectations of patients and families and to prepare for the future with the prospect of a treatment.

The work you will undertake, Professor, with the members of the commission, must result in a plan that is not merely a continuation of previous plans. I wish for the objectives of the Alzheimer Plan that you propose to express this difference. To achieve this, you must mobilize around your commission the best experts from the medical and scientific fields and those most open to the suffering of others.

First and foremost, your work must be guided by the goal of better understanding and diagnosing the disease. Research must occupy a privileged place in your work. Research efforts must be stimulated and federated, in both fundamental and clinical research. All research avenues must be explored, without exclusion. I hope that these efforts will lead to the discovery or validation of a diagnosis and treatment in France. The Alzheimer Plan is an opportunity to demonstrate the excellence of French research, to make it more competitive, and to catalyze all its energies, regardless of the legal entity that houses them.

I need you to propose measures for organizing a true epidemiological follow-up of Alzheimer’s disease and related illnesses, in order to understand and monitor the situation. It is essential that the evolution of the number of patients is known with precision.

The progress that will be made in understanding and diagnosing the disease will undoubtedly change our perspective on it. I also expect the Alzheimer Plan to lead us to speak differently to patients and about the disease. Changing our perspective and our words is in itself a form of support and assistance for patients.

Secondly, I ask you to design actions that concretely improve the overall quality of care for the disease and its consequences. For what use is an early diagnosis if treatments do not change the progression of the disease and if care methods retain their current shortcomings? We owe a quality response to people who will be ill for several years, sometimes several decades. Alzheimer’s disease is a chronic disabling illness; we must draw the consequences from that. Therefore, we must maintain the quality of care over time, at all stages of cognitive function impairment. On the crucial point of care quality, your work must provide avenues for measuring it and making it transparent for all. The question of new professions necessary to meet these new needs must be fully addressed. A considerable training effort is the condition for the development of these new professions.

Thirdly, you will pay particular attention to the freedom of choice of patients and their families. I especially want the choice of remaining at home, when possible, to be respected. In this perspective, you will make proposals to strengthen the continuity and territorial equity of care. The freedom of choice for patients and families is a chimera without a credible communication and orientation system in their favor. Too often, families, when the disease is diagnosed, do not know where to turn. It is essential to guide patients and families in their journeys.

Finally, you must place the utmost importance on the goal of integrating research, care, and social support. This is where the Alzheimer Plan will particularly differentiate itself from previous initiatives. Your proposals must facilitate the acceleration of the transfer of research progress to care and the transfer of field observations to research. The continuity of research throughout the patient’s journey is the main objective I intend to assign to the Alzheimer Plan. The integration of research, health, and solidarity will be the hallmark of the Alzheimer Plan.

I want the identity of the Plan to also be perceived in its method. I encourage you to take all viewpoints into account. I want you to consider information from field actors, who are in contact with the patient and their family. Given the short duration of your mission, I invite you to create an online forum to gather, once your proposal work is completed, the opinions of professionals and the French public.

Naturally, evaluation will be at the heart of the Alzheimer Plan's method. You will formulate precise proposals regarding the evaluation of the measures and results of the Plan. In particular, objective criteria for the quality of research, care, and social support must be selected and made transparent. The evaluation must be conducted by a panel of personalities from different disciplines and nationalities. It should provide an opportunity to compare the Alzheimer Plan with initiatives from other countries. The demand for evaluation is a demand for excellence; I know you are convinced of this.

I ask you to propose operational, quantified measures, clearly identifying the person responsible for their implementation. The demand for results must inspire all your work.

I wish for you to present the Alzheimer Plan to me by November 1st. After that, a phase of dialogue can take place between patient associations, professionals, and the ministries responsible for implementing your proposals. Your mission must mark the starting point of a permanent and ongoing dialogue with all actors in the fight against the disease.

The implementation of the Alzheimer Plan will begin on January 1, 2008. As you know, I wished for you to submit initial orientations to me by September 21, the date of World Alzheimer’s Day, which this year focuses on young patients.

I want to thank you, Professor, Ladies and Gentlemen, for the time and experience you will dedicate to a decisive action for the health of the French people and the lives of families.